基本信息
views: 25

Bio
My scientific interests concern the field of neuropsychopharmacology, particularly in the context of schizophrenia and depression, both in clinical and experimental pharmacology (based on animal research). In addition, I am interested in the secondary studies area (systematic reviews and meta-analyses). In addition to 10-year research experience, I have teaching experience in pharmacoeconomics and health technology assessment.
Research Interests
Papers共 85 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical infectious diseases an official publication of the Infectious Diseases Society of America (2025)
Piotr Ratajczak, Katarzyna Oziewicz, Isolde Sommer,Dorota Kopciuch,Anna Paczkowska,Tomasz Zaprutko,Krzysztof Kus
Healthcare (Basel, Switzerland)no. 8 (2025)
Tomasz Zaprutko,Julia Cynar, Maria Sygit,Aleksandra Stolecka, Patrycja Skorupska, Paulina Jaszcz,Dorota Kopciuch,Anna Paczkowska,Piotr Ratajczak,Krzysztof Kus
JOURNAL OF CLINICAL MEDICINEno. 11 (2024)
Dorota Kopciuch,Karolina Hoffmann,Krzysztof Kus, Agnieszka Koligat-Seitz,Piotr Ratajczak,Elzbieta Nowakowska,Anna Paczkowska
Dorota Kopciuch,Karolina Hoffmann,Krzysztof Kus, Agnieszka Koligat-Seitz,Piotr Ratajczak,Elżbieta Nowakowska,Anna Paczkowska
openalex(2024)
Tomasz Zaprutko,Jozefina Sprawka, Barbara Maciuszek-Bartkowska,Piotr Ratajczak,Dorota Kopciuch,Anna Paczkowska,Krzysztof Kus
SCIENTIA PHARMACEUTICAno. 1 (2024)
Piotr Ratajczak, Jakub Martyński, Jan Kazimierz Zięba, Katarzyna Świło,Dorota Kopciuch,Anna Paczkowska,Tomasz Zaprutko,Krzysztof Kus
Pharmaceuticsno. 9 (2024)
VACCINESno. 1 (2024)
Load More
Author Statistics
#Papers: 85
#Citation: 651
H-Index: 12
G-Index: 23
Sociability: 5
Diversity: 3
Activity: 22
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn